Evidence map›Paper›PMID 35674929›Full record

ArticleNeurochemical research2022

ß-Hydroxybutyrate Improves Mitochondrial Function After Transient Ischemia in the Mouse.

Alina Lehto, Konrad Koch, Johanna Barnstorf-Brandes, Christian Viel, Marius Fuchs, Jochen Klein

Open access · hybridAbstract read
In one paragraph

Article in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. β-Hydroxybutyrate Exposure is Associated with Increased THCellular and molecular neurobiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Blood and Brain Metabolites after Cerebral Ischemia.International journal of molecular sciences · 2023
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Alina LehtoDepartment of Pharmacology and Clinical Pharmacy, College of Pharmacy, Goethe University of Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany.
Konrad KochInstitute of Legal Medicine, Kanton Basel, Basel, Switzerland.
Johanna Barnstorf-BrandesDepartment of Pharmacology and Clinical Pharmacy, College of Pharmacy, Goethe University of Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany.
Christian VielDepartment of Pharmacology and Clinical Pharmacy, College of Pharmacy, Goethe University of Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany.
Marius FuchsDepartment of Pharmacology and Clinical Pharmacy, College of Pharmacy, Goethe University of Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany.
Jochen KleinDepartment of Pharmacology and Clinical Pharmacy, College of Pharmacy, Goethe University of Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany. klein@em.uni-frankfurt.de.
Goethe University Frankfurt · DEKantonsspital Baselland · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ß-Hydroxybutyrate (BHB) is a ketone body formed in high amounts during lipolysis and fasting. Ketone bodies and the ketogenic diet were suggested as neuroprotective agents in neurodegenerative disease. In the present work, we induced transient ischemia in mouse brain by unilaterally occluding the middle cerebral artery for 90 min. BHB (30 mg/kg), given immediately after reperfusion, significantly improved the neurological score determined after 24 h. In isolated mitochondria from mouse brain, oxygen consumption by the complexes I, II and IV was reduced immediately after ischemia but recovered slowly over 1 week. The single acute BHB administration after reperfusion improved complex I and II activity after 24 h while no significant effects were seen at later time points. After 24 h, plasma and brain BHB concentrations were strongly increased while mitochondrial intermediates (citrate, succinate) were unchanged in brain tissue. Our data suggest that a single administration of BHB may improve mitochondrial respiration for 1-2 days but not for later time points. Endogenous BHB formation seems to complement the effects of exogenous BHB administration.

Indexed as

Neurodegenerative DiseasesNeuroprotective Agents3-Hydroxybutyric AcidAnimalsCitratesHydroxybutyratesIschemiaKetone BodiesMiceMitochondriaSuccinates3-Hydroxybutyric AcidCitratesHydroxybutyratesKetone BodiesNeuroprotective AgentsSuccinatesComplex IComplex IIGlucoseMicrodialysisOxidative phosphorylationStroke

Identifiers

PMID35674929
PMCPMC9546981
OpenAlexW4282935042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.